Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

This study has been completed.
Sponsor:
Collaborator:
Ono Pharmaceutical Co. Ltd
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00794443
First received: November 18, 2008
Last updated: April 30, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)